View in EDS

SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.

Saved in:
Bibliographic Details
Title: SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Authors: Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Sharma MR; START Midwest, Grand Rapids, Michigan., Johnson ML; Sarah Cannon Research Institute, Nashville, Tennessee., Yap TA; The University of Texas MD Anderson Cancer Center, Houston, Texas., Gadgeel S; Henry Ford Cancer Center/Henry Ford Health, Detroit, Michigan., Nepert D; Pfizer Boulder Research Unit, Boulder, Colorado., Feng G; Early Clinical Development, Pfizer, Inc., Cambridge, Massachusetts., Reddy MB; Pfizer Boulder Research Unit, Boulder, Colorado., Harney AS; Pfizer Boulder Research Unit, Boulder, Colorado., Elsayed M; Pfizer Boulder Research Unit, Boulder, Colorado., Cook AW; Pfizer Boulder Research Unit, Boulder, Colorado., Wong CE; Pfizer Boulder Research Unit, Boulder, Colorado., Hinklin RJ; Pfizer Boulder Research Unit, Boulder, Colorado., Jiang Y; Pfizer Boulder Research Unit, Boulder, Colorado., Brown EN; Pfizer Boulder Research Unit, Boulder, Colorado., Neitzel NA; Pfizer Boulder Research Unit, Boulder, Colorado., Laird ER; Pfizer Boulder Research Unit, Boulder, Colorado., Wu WI; Pfizer Boulder Research Unit, Boulder, Colorado., Singh A; Pfizer Boulder Research Unit, Boulder, Colorado., Wei P; Pfizer Oncology Research and Development, La Jolla, California., Ching KA; Pfizer Oncology Research and Development, La Jolla, California., Gaudino JJ; Pfizer Boulder Research Unit, Boulder, Colorado., Lee PA; Pfizer Boulder Research Unit, Boulder, Colorado., Hartley DP; Pfizer Boulder Research Unit, Boulder, Colorado., Rothenberg SM; Pfizer Boulder Research Unit, Boulder, Colorado.; Pfizer Oncology Research and Development, La Jolla, California.
Source: Cancer discovery [Cancer Discov] 2023 Aug 04; Vol. 13 (8), pp. 1789-1801.
Publication Type: Editorial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37269335
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Drilon+A%22">Drilon A</searchLink>; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Sharma+MR%22">Sharma MR</searchLink>; START Midwest, Grand Rapids, Michigan.<br /><searchLink fieldCode="AU" term="%22Johnson+ML%22">Johnson ML</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Yap+TA%22">Yap TA</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gadgeel+S%22">Gadgeel S</searchLink>; Henry Ford Cancer Center/Henry Ford Health, Detroit, Michigan.<br /><searchLink fieldCode="AU" term="%22Nepert+D%22">Nepert D</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Feng+G%22">Feng G</searchLink>; Early Clinical Development, Pfizer, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Reddy+MB%22">Reddy MB</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Harney+AS%22">Harney AS</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Elsayed+M%22">Elsayed M</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Cook+AW%22">Cook AW</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Wong+CE%22">Wong CE</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Hinklin+RJ%22">Hinklin RJ</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Brown+EN%22">Brown EN</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Neitzel+NA%22">Neitzel NA</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Laird+ER%22">Laird ER</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Wu+WI%22">Wu WI</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Singh+A%22">Singh A</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Wei+P%22">Wei P</searchLink>; Pfizer Oncology Research and Development, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Ching+KA%22">Ching KA</searchLink>; Pfizer Oncology Research and Development, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Gaudino+JJ%22">Gaudino JJ</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Lee+PA%22">Lee PA</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Hartley+DP%22">Hartley DP</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.<br /><searchLink fieldCode="AU" term="%22Rothenberg+SM%22">Rothenberg SM</searchLink>; Pfizer Boulder Research Unit, Boulder, Colorado.; Pfizer Oncology Research and Development, La Jolla, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2023 Aug 04; Vol. 13 (8), pp. 1789-1801.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37269335
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2159-8290.CD-23-0361
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1789
    Titles:
      – TitleFull: SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Drilon A
      – PersonEntity:
          Name:
            NameFull: Sharma MR
      – PersonEntity:
          Name:
            NameFull: Johnson ML
      – PersonEntity:
          Name:
            NameFull: Yap TA
      – PersonEntity:
          Name:
            NameFull: Gadgeel S
      – PersonEntity:
          Name:
            NameFull: Nepert D
      – PersonEntity:
          Name:
            NameFull: Feng G
      – PersonEntity:
          Name:
            NameFull: Reddy MB
      – PersonEntity:
          Name:
            NameFull: Harney AS
      – PersonEntity:
          Name:
            NameFull: Elsayed M
      – PersonEntity:
          Name:
            NameFull: Cook AW
      – PersonEntity:
          Name:
            NameFull: Wong CE
      – PersonEntity:
          Name:
            NameFull: Hinklin RJ
      – PersonEntity:
          Name:
            NameFull: Jiang Y
      – PersonEntity:
          Name:
            NameFull: Brown EN
      – PersonEntity:
          Name:
            NameFull: Neitzel NA
      – PersonEntity:
          Name:
            NameFull: Laird ER
      – PersonEntity:
          Name:
            NameFull: Wu WI
      – PersonEntity:
          Name:
            NameFull: Singh A
      – PersonEntity:
          Name:
            NameFull: Wei P
      – PersonEntity:
          Name:
            NameFull: Ching KA
      – PersonEntity:
          Name:
            NameFull: Gaudino JJ
      – PersonEntity:
          Name:
            NameFull: Lee PA
      – PersonEntity:
          Name:
            NameFull: Hartley DP
      – PersonEntity:
          Name:
            NameFull: Rothenberg SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 08
              Text: 2023 Aug 04
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2159-8290
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Cancer discovery
              Type: main
ResultId 1